Alginate Lyase Exhibits Catalysis-Independent Biofilm Dispersion and Antibiotic Synergy

Por Lamppa, John W., Griswold, Karl E.
Publicado em 2013

Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent

Por Osipovitch, Daniel C., Griswold, Karl E.
Publicado no FEMS Microbiol Lett (2014)

Design and Engineering of Deimmunized Biotherapeutics

Por Griswold, Karl E., Bailey-Kellogg, Chris
Publicado no Curr Opin Struct Biol (2016)

Direct selection of trans-acting ligase ribozymes by in vitro compartmentalization

Por LEVY, MATTHEW, GRISWOLD, KARL E., ELLINGTON, ANDREW D.
Publicado em 2005

Structure-based redesign of proteins for minimal T-cell epitope content

Por Choi, Yoonjoo, Griswold, Karl E., Bailey-Kellogg, Chris
Publicado em 2013

Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity

Por Osipovitch, Daniel C., Therrien, Sophie, Griswold, Karl E.
Publicado no Appl Microbiol Biotechnol (2015)

Optimization of Combinatorial Mutagenesis

Por Parker, Andrew S., Griswold, Karl E., Bailey-Kellogg, Chris
Publicado no J Comput Biol (2011)

Quantifying and resolving multiple vector transformants in <it>S. cerevisiae </it>plasmid libraries

Por Gray Elizabeth C, Scanlon Thomas C, Griswold Karl E
Publicado em 2009-11-01

Quantifying and resolving multiple vector transformants in S. cerevisiae plasmid libraries

Por Scanlon, Thomas C, Gray, Elizabeth C, Griswold, Karl E
Publicado em 2009

Engineering Escherichia coli for Soluble Expression and Single Step Purification of Active Human Lysozyme

Por Lamppa, John W., Tanyos, Sam A., Griswold, Karl E.
Publicado em 2012

A High-Throughput Screen for Antibiotic Drug Discovery

Por Scanlon, Thomas C., Dostal, Sarah M., Griswold, Karl E.
Publicado em 2013

The Evolution of Catalytic Efficiency and Substrate Promiscuity in Human Theta Class 1-1 Glutathione Transferase

Por Griswold, Karl E., Aiyappan, Nandini S., Iverson, Brent L., Georgiou, George
Publicado em 2006

Optimization algorithms for functional deimmunization of therapeutic proteins

Por Parker, Andrew S, Zheng, Wei, Griswold, Karl E, Bailey-Kellogg, Chris
Publicado em 2010

Structure-Guided Deimmunization of Therapeutic Proteins

Por Parker, Andrew S., Choi, Yoonjoo, Griswold, Karl E., Bailey-Kellogg, Chris
Publicado em 2013

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Por Salvat, Regina, Moise, Leonard, Bailey-Kellogg, Chris, Griswold, Karl E.
Publicado em 2014

Computationally driven antibody engineering enables simultaneous humanization and thermostabilization

Por Choi, Yoonjoo, Ndong, Christian, Griswold, Karl E., Bailey-Kellogg, Chris
Publicado no Protein Eng Des Sel (2016)

EpiSweep: Computationally-driven Reengineering of Therapeutic Proteins to Reduce immunogenicity while Maintaining Function

Por Choi, Yoonjoo, Verma, Deeptak, Griswold, Karl E., Bailey-Kellogg, Chris
Publicado no Methods Mol Biol (2017)

Magnetic nanoparticle hyperthermia induced cytosine deaminase expression in microencapsulated E. coli for enzyme-prodrug therapy

Por Nemani, Krishnamurthy V., Ennis, Riley C., Griswold, Karl E., Gimi, Barjor
Publicado no J Biotechnol (2015)

Going native: Direct high throughput screening of secreted full-length IgG antibodies against cell membrane proteins

Por Fang, Yongliang, Chu, Thach H., Ackerman, Margaret E., Griswold, Karl E.
Publicado no MAbs (2017)

The monoclonal myth

Por Scanlon, Thomas C, Jewell, Heather L, Gray, Elizabeth C, Griswold, Karl E
Publicado em 2010